首页>投融资
SingleTimeMicroneedles
种子轮
SingleTimeMicroneedles开发了一种药物和疫苗微针给药平台,使动物和人类能够获得医药产品。这种微针贴片能稳定药物和疫苗的温度,无需冷链储存和运输。这种贴片可以立即给药,也可以在一段时间内给药,还可以在一次应用中分别给药数周或数月。该技术可支持大多数类型的疫苗和疗法,包括大分子、亚单位蛋白抗原、载体疫苗、mRNA以及任何可受益于多次/长期给药的化合物。STM贴片应用广泛,目前正计划用于动物和人类。
基本信息
-
公司全称SingleTimeMicroNeedles Inc
-
类型药物和疫苗微针给药平台开发商
-
产业领域医疗器械、治疗设备
-
公司人数15人以下
-
地址400 Farmington Ave, Rm 1844 Farmington
-
联系电话1 860-847-0138
-
邮箱jasdeep.singh@stmpatch.com
-
成立时间2022-03-15
投融资
-
2024-02-14种子轮未透露Health Advance Partners
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
BetaGlue Therapeutics是一家临床分期肿瘤公司,该公司开发了一种先进的放疗平台,能够对不可切除的实体瘤和手术切缘进行局部靶向治疗,称为YntraDose。